CLB logo

Core Laboratories Inc. Stock Price

NYSE:CLB Community·US$642.6m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

CLB Share Price Performance

US$0
-11.03 (-100.00%)
US$16.33
Fair Value
US$0
-11.03 (-100.00%)
Price US$0

CLB Community Narratives

·
Fair Value US$16.33 16.3% undervalued intrinsic discount

Middle East And Asia Pacific Markets Will Secure Energy Success

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value US$22 37.9% undervalued intrinsic discount

Middle East And Latin America Will Accelerate Oilfield Reservoir Optimization

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$10 36.7% overvalued intrinsic discount

Legacy Oilfield Demand Will Plunge As Renewables Expand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$16.33
16.3% undervalued intrinsic discount
Revenue
1.6% p.a.
Profit Margin
8.06%
Future PE
19.5x
Price in 2029
US$19.9
US$10
36.7% overvalued intrinsic discount
Revenue
-0.31% p.a.
Profit Margin
7.85%
Future PE
14.45x
Price in 2028
US$12.44

Trending Discussion

Updated Narratives

CLB logo

CLB: Middle East Disruptions Will Shape Undervalued Shares And Future P/E

Fair Value: US$22 37.9% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CLB logo

CLB: Fair Outlook Balances Middle East Disruptions And Governance Changes

Fair Value: US$16.33 16.3% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CLB logo

Legacy Oilfield Demand Will Plunge As Renewables Expand

Fair Value: US$10 36.7% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with acceptable track record.

1 Risk
3 Rewards

Core Laboratories Inc. Key Details

US$524.7m

Revenue

US$420.2m

Cost of Revenue

US$104.5m

Gross Profit

US$75.5m

Other Expenses

US$29.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.63
19.92%
5.53%
41.6%
View Full Analysis

About CLB

Founded
1936
Employees
3300
CEO
Lawrence Bruno
WebsiteView website
www.corelab.com

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Recent CLB News & Updates

Narrative Update May 23

CLB: Middle East Disruptions Will Shape Undervalued Shares And Future P/E

Analysts have kept their $22.00 price target for Core Laboratories unchanged, citing updated assumptions that include a slightly higher discount rate and revenue growth outlook, along with a marginally lower profit margin and P/E expectation. What's in the News Core Laboratories revised its first quarter 2026 guidance, now expecting revenue between US$119,000,000 and US$123,000,000, operating income ex-items of US$5,700,000 to US$7,100,000, and EPS ex-items of US$0.05 to US$0.07, citing impacts from geopolitical conflict in the Middle East, client project delays, travel limits, and supply chain disruptions (Key Developments).
Narrative Update Apr 28

CLB: Fair Outlook Balances Middle East Disruptions And Governance Changes

Analysts have raised their price target on Core Laboratories from about $14.00 to roughly $16.33, citing updated views on fair value, discount rate, revenue growth, profit margins, and future P/E assumptions. What's in the News Core Laboratories revised its first quarter 2026 earnings guidance, citing client driven project delays, travel constraints, and supply chain disruptions linked to geopolitical conflict in the Middle East, and now expects revenue of US$119,000,000 to US$123,000,000 and EPS, ex items, of US$0.05 to US$0.07 for the period (Key Developments).

Recent updates

No updates